CBSCBS News·1hHealth
score+0.30
FDA panel to consider loosening regulations for some peptides
Original
FDA panel to consider loosening regulations for some peptides
“Neutral regulatory language ('consider,' 'review') with mildly positive framing of expanded access without catastrophizing or excessive optimism.”